Diabetic Emergencies - PowerPoint PPT Presentation

1 / 46
About This Presentation
Title:

Diabetic Emergencies

Description:

complications of treatment e.g cerebral oedema, hypokalaemia. HONK mortality 15 ... 0.9% saline 1 L/hour and/or plasma expander. Once stabilised ... – PowerPoint PPT presentation

Number of Views:245
Avg rating:3.0/5.0
Slides: 47
Provided by: mar339
Category:

less

Transcript and Presenter's Notes

Title: Diabetic Emergencies


1
Diabetic Emergencies
  • Dr. Mohamed Suliman

2
Diabetic Emergencies
  • Common
  • Acute hyperglycaemia with no acidosis
  • Hypoglycaemia
  • DKA
  • Less common
  • HONK
  • Lactic Acidosis

3
Mortality
  • DKA Mortality 2-5
  • Cause of death
  • - DKA
  • - Underlying cause of DKA, e.g
    infection, MI
  • - complications of treatment e.g
    cerebral oedema, hypokalaemia
  • HONK mortality 15
  • Lactic Acidosis mortality up to 50

4
Acute hyperglycaemia with no acidosis
  • Known diabetic (type 1 or type 2)
  • Acute intercurrent illness e.g infection
  • Drugs e.g steroids leading to
    deterioration in control
  • Newly diagnosed type 1 diabetes

5
Management of acute hyperglycaemia in a known
diabetic
  • Rule out DKA and HONK
  • Is the patient unwell/unstable? e.g vomiting,
    dehydrated
  • If yes admit and stabilise (IV insulin sliding
    scale, IV fluids)
  • Treat underlying cause e.g infection
  • If no arrange review by DSN/diabetes team and
    discharge

6
Newly diagnosed diabetic with no DKA
  • Features suggesting type 1 diabetes
  • Marked osmotic symptoms (polyuria, polydepsia,
    weight loss)
  • Short history (days to weeks)
  • Younger age (lt30 years old)
  • Ketonuria
  • BMI lt25

7
Management of newly diagnosed type 1 diabetic
with no DKA
  • Is the patient unwell/unstable ?e.g vomiting,
    dehydrated
  • Yes treat as in-patient with IV insulin until
    eating and drinking
  • No early discharge after review by DSN/diabetes
    team

8
Pathogenesis of DKA and HONK
  • Pathogenesis of DKA is better understood than
    that of HONK
  • A reduction in the net effective concentration
    of insulin
  • Elevation in counter-regulatory hormones
    (Glucagon, Cortisol, GH, catecholamines)

9
DKA
  • Absolute Insulin deficiency

Lipolysis
Hyperglycaemia
Ketones
Dehydration
Metabolic acidosis
10
HONK
Relative insulin deficiency
Reduced thirst
Minimal/absent ketogenesis
Hyperglycaemia
Dehydration
Hyperosmolality
11
DKA or HONK?
12
What are the precipitating causes of DKA?
13
DKA clinical presentation
  • Symptoms
  • Vomiting
  • Abdominal pain
  • Shortness of breath
  • Symptoms of precipitating condition
  • Signs
  • Dehydration
  • Tachycardia and hypotension
  • Hyperventilation (Kussmaul respiration)
  • Drowsiness/coma
  • Ketones on breath

14
DKADiagnostic criteria
  • Plasma glucosegt14mmol/L
  • Urinary ketones gt
  • Venous bicarbonate lt 18 and/or arterial pH lt 7.30

15
Initial assessment
  • Airway
  • Consider NGT in a vomiting or
    semi-conscious patient
  • Breathing
  • Monitor oxygen saturations
  • Circulation pulse, BP
  • Start IV normal saline (1 L in 1 Hour)
  • Contact senior help
  • Diagnosis
  • Baseline investigations UEs, glucose,
    FBC, venous bicarbonate (or ABGs)

16
Should ABGs be done in all patients with
suspected DKA?
  • No!
  • Consider in those with
  • Reduced level of consciousness
  • Respiratory distress
  • Hypotension
  • In patients who appear clinically well, venous
    bicarbonate is enough to confirm diagnosis

17
Who to consider for ICU?
  • pH lt7.0
  • Reduced GCS lt10
  • Hypotension (Systolic BP lt90)
  • No clinical signs of improvement after 1st hour
    of treatment

18
Initial management
  • Once diagnosis confirmed, treat according to DKA
    protocol
  • IV insulin sliding scale
  • IV fluids
  • Potassium replacement

19
Secondary assessment
  • Full history and examination to check for
    precipitating factors
  • CXR/ECG and Blood/urine cultures if sepsis
    suspected
  • Specific treatments for identified precipitants
    (e.g infection/MI)

20
Ongoing review
  • Review patient (SHO/SpR) at 1 hour, 2 hours, 4
    hours, and 8 hours and other times if needed
  • Repeat UEs and venous bicarbonate (or ABGs) at
    2, 4 and 8 hours

21
How much fluids should I give?
Initial evaluation. Start iv fluids 1L of 0.9
saline in 1st hour
Hypovolaemic shock (sBP lt 90)
Cardiogenic Shock
Mild hypotension or normal BP
Haemodynamic monitoring to guide fluid
replacement in ICU
0.9 saline 1 L/hour and/or plasma expander
0.9 saline 500 ml/hour for 4 hours can be
adjusted according to haemodynamic status
Once stabilised
0.9 saline 250ml/hour for next 8hours then
125ml/hour - can be adjusted according to
haemodynamic status
22
Which type of fluid should I use?
  • Normal saline is the standard replacement
  • If corrected sodium gt148 mmol/l use 0.45 saline.
  • Corrected sodium
  • Plasma Sodium (plasma glucose-6)
    3.5
  • When plasma glucose ?14 mmol/l change from saline
    to 5 dextrose
  • Fluid deficit is usually 5-8 litres and the aim
    is to replace it in 24-48 hours

23
When to consider IV bicarbonate?
  • Bicarbonate should only be considered in severe
    acidosis (pH lt7) with impending cardiovascular
    or respiratory collapse
  • Usually in an ICU setting
  • 500 ml of Sodium bicarbonate 1.26 with 20 mmol
    KCl over 30 minutes

24
Insulin
  • IV Actrapid 0.15 units/kg (e.g 10 units)
  • Commence IV insulin sliding scale adjust
    according to hourly capillary glucose
  • Aim to reduce glucose levels by 4-7 mmol/l/hour

25
Potassium
Potassium (mmol/l) Action
lt3.3 KCl 40 mmol/l in first hour and
withhold insulin until K gt3.3
3.3-4.0 KCl 40 mmol in each litre of fluid
4.0-5.5 KCl 20 mmol in each litre of fluid
gt5.5 withhold KCl and check every 2 hours
26
When do you take down the sliding scale?
  • Bicarb gt 18mmol/l and or pH gt 7.30
  • Patient is eating and drinking
  • Ketonuria 1 or less

27
How do you take down the sliding scale?
  • Best to take sliding scale down in the morning
    where possible.
  • Continue sliding scale for 30mins after first sc
    injection of short-acting insulin
  • Ask DSN to see as soon as patient ready to switch
    to sc insulin
  • If ketonuria returns reassess need for restarting
    sliding scale

28
What subcutaneous insulin regime should you start
the patient on?
  • Convert to previous insulin regime if patient
    well controlled prior to admission
  • OR
  • Calculate insulin requirements over 24 hrs and
    convert to qds regime using Novorapid tds pre
    meal and Insulatard pre bed.
  • Give 1/3 total dose insulin as insulatard pre bed
    and the remainder split into 3 Novorapid doses
    pre meal

29
DKAPrevention
  • Sick day rules
  • Continue your insulin when you are not feeling
    well
  • If vomiting check glucose levels more frequently
  • Take small amounts of CHO in liquid form with
    short-acting insulin
  • Seek help early if you continue to feel unwell

30
HONKDiagnostic criteria
  • Plasma glucose gt 30mmol/l
  • Plasma Osmolality gt 320mOsm/Kg
  • Urinary ketones
  • pH gt 7.30 and HCO3 18
  • plasma osmolality 2(Na K) glucose urea

31
HONK differences in management form DKA
  • On initial assessment check osmolality
  • Consider anticoagulation in severe
    hyperosmolality
  • Consider 0.45 saline instead of normal saline if
    corrected Nagt148 mmol/l
  • Fluid deficit 8-15 litres, aim to replace it over
    48 hours.

32
HONK differences in management form DKA
  • Patients may be more insulin-sensitive and need
    smaller doses of insulin
  • Take sliding scale down when patient is
    clinically better and eating and drinking
  • If previously on OHA, continue sc insulin for 2-3
    days before considering restarting OHAs.
  • Most patients can eventually be managed on diet
    only or OHAs.

33
Hypoglycaemia in a diabetic patient
  • Usually caused by insulin or a sulphonylurea e.g
    Gliclazide or Glibenclamide
  • Metformin and the Glitazones (Rosiglitazone and
    Pioglitazone) do not cause hypoglycaemia

34
Hypoglycaemia in a diabetic patient - symptoms
  • Shaking
  • Hunger
  • Palpitations
  • Sweating
  • Incoordination
  • Visual disturbance
  • Nausea
  • Malaise
  • Confusion
  • Drowsiness
  • Speech difficulty
  • Atypical behaviour

35
Hypoglycaemia in a diabetic patient special
considerations in the elderly
  • Hypoglycaemia is common in elderly patients
  • Symptoms may be unrecognised
  • Extra care should be taken with elderly patients
    taking long-acting sulphonylureas e.g
    Glibenclamide

36
Hypoglycaemia in a diabetic patient making the
diagnosis
  • Establish the diagnosis quickly if practically
    possible by measuring a finger prick capillary
    blood glucose
  • A level of lt4 mmol/l suggests that the symptoms
    are caused by hypoglycaemia.
  • If there is likely to be any difficulty with
    performing the test
  • Treatment should not be delayed.

37
Hypoglycaemia in a diabetic patient Treatment
  • If the patient is able to take orally any
    available glucose drink.
  •  
  • Repeat after 5 minutes if no improvement in
    symptoms
  • Oral glucose should be followed by complex
    carbohydrates e.g a sandwich.
  • Check the blood glucose every half an hour until
    it has risen to over 4 mmol/l.

38
Hypoglycaemia in a diabetic patient Treatment
  • If oral administration is not possible
  •  Intramuscular (or subcutaneous) Glucagon 1 mg
    (treatment of choice )
  • After recovery, oral carbohydrate should be
    given.
  • If there is no response within 10 minutes,
    intravenous glucose should be administered.

39
Hypoglycaemia in a diabetic patient Treatment
  • Intravenous glucose
  • 50 ml dextrose 50 into a large vein or 100 ml of
    20 dextrose.
  • If there is failure to recover consciousness
    within 20 minutes, an intravenous infusion of 10
    dextrose should be started and the blood glucose
    concentration should be maintained between 8-12
    mmol/l.

40
Hypoglycaemia in a diabetic patient monitoring
after initial treatment
  •  If hypoglycaemia was induced by
  • a sulphonylurea
  • or
  • an intermediate-acting or long-acting insulin
    (e.g Insultard, Humulin I, Lantus, Levemir)
  • do regular monitoring of capillary glucose levels
    every 2-4 hours for the following 12-24 hours.

41
Hypoglycaemia in a diabetic patient Prevention
  •  Reassess diabetes control and targets
  • Check HbA1c, glucose levels on home monitoring
  • Are control targets appropriate for the patient?
    (e.g elderly, living alone with tight control)
  • Adjust treatment
  • Re-educate the patient
  • DSN review/diabetes team follow up

42
Metformin-associated Lactic Acidosis
  • Uncommon but potentially fatal complication of
    Metformin treatment
  • Metformin is the most widely used diabetic
    medication
  • Risk factors renal failure, sepsis, severe
    congestive heart failure, shock

43
Metformin-associated Lactic Acidosis- diagnosis
  • Features of metabolic acidosis
  • Tachycardia,
  • Hypotension
  • Vasodilatation
  • Hyperventilation
  • Clouded consciousness
  • Features of the underlying precipitating
    problem e.g sepsis, renal failure
  • If suspected, check ABGs including lactate level
    (normal lt4mmol/l)

44
Metformin-associated Lactic Acidosis- treatment
  • Usually very sick patient
  • Treat underlying cause e.g sepsis
  • Treat in ICU/HDU
  • Haemofiltration may be needed for renal failure
    and to eliminate Metformin

45
Metformin-associated Lactic Acidosis- prevention
  • Stop Metformin in
  • patients with creatinine gt150 (eGFRlt30 ml/min)
  • patients admitted with severe heart failure,
    hypotension, sepsis
  • patients undergoing IV radiocontrast studies

46
Questions?
Write a Comment
User Comments (0)
About PowerShow.com